Literature DB >> 15805724

Mild hepatic fibrosis in cholesterol and sodium cholate diet-fed rats.

Won-Il Jeong1, Da-Hee Jeong, Sun-Hee Do, Yoo-Kyeong Kim, Ho-Yong Park, Oh-Deog Kwon, Tae-Hwan Kim, Kyu-Shik Jeong.   

Abstract

To date, the majority of research on hypercholesterolemia has focused on the effects of a high cholesterol diet on atherosclerosis and coronary heart disease. The toxic effects of cholesterol on the liver and the relationship between the intake of a high cholesterol diet and hepatic fibrosis, however, have not been investigated clearly or histopathologically. Male Wistar rats were fed a diet supplemented with 1.0% cholesterol and 0.3% sodium cholate for 12 weeks. Rats were sacrificed and analyzed via blood biochemistry, traditional microscopy and immunohistochemistry. Following the feeding of this diet, the rates of aspartate aminotransferase, alanine aminotransferase, lactate dehydrogenase and total cholesterol in the rats were elevated consistently from week 3 and throughout the remainder of the experiment. From microscopic observation, hepatic necrosis, macrophage infiltration and steatosis increased markedly throughout the experiment. Hepatic fibrosis and myofibroblast proliferation were detected at weeks 9 and 12. Mast cell appearance was proportional to the degree of hepatic damage. These findings suggest that hepatic fibrosis is inducible by a high cholesterol diet and is likely the result of the interaction between several different cell types (i.e., macrophages, myofibroblasts, and mast cells) in an inflammatory milieu. Hypercholesterolemia should be considered as a risk factor for hepatic fibrosis as well as atherosclerosis and coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15805724     DOI: 10.1292/jvms.67.235

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  22 in total

1.  Cytoplasmic tyrosine phosphatase Shp2 coordinates hepatic regulation of bile acid and FGF15/19 signaling to repress bile acid synthesis.

Authors:  Shuangwei Li; Diane D F Hsu; Bing Li; Xiaolin Luo; Nazilla Alderson; Liping Qiao; Lina Ma; Helen H Zhu; Zhao He; Kelly Suino-Powell; Kaihong Ji; Jiefu Li; Jianhua Shao; H Eric Xu; Tiangang Li; Gen-Sheng Feng
Journal:  Cell Metab       Date:  2014-06-26       Impact factor: 27.287

2.  Sources of cells that contribute to atherosclerotic intimal calcification: an in vivo genetic fate mapping study.

Authors:  Veena Naik; Elizabeth M Leaf; Jie Hong Hu; Hsueh-Ying Yang; Ngoc B Nguyen; Cecilia M Giachelli; Mei Y Speer
Journal:  Cardiovasc Res       Date:  2012-03-21       Impact factor: 10.787

3.  Chrysin attenuates high-fat-diet-induced myocardial oxidative stress via upregulating eNOS and Nrf2 target genes in rats.

Authors:  Subramani Yuvaraj; Tharmarajan Ramprasath; Balakrishnan Saravanan; Varadaraj Vasudevan; Sundaresan Sasikumar; Govindan Sadasivam Selvam
Journal:  Mol Cell Biochem       Date:  2021-03-07       Impact factor: 3.396

Review 4.  Animal models of nonalcoholic fatty liver disease.

Authors:  Lionel Hebbard; Jacob George
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-30       Impact factor: 46.802

5.  Nutritional model of steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.

Authors:  Lydia Lee; Mouhamad Alloosh; Romil Saxena; William Van Alstine; Bruce A Watkins; James E Klaunig; Michael Sturek; Naga Chalasani
Journal:  Hepatology       Date:  2009-07       Impact factor: 17.425

6.  Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks.

Authors:  Mohammed Elmowafy; Hany M Ibrahim; Mohammed A Ahmed; Khaled Shalaby; Ayman Salama; Hossam Hefesha
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

7.  Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review.

Authors:  Tong-Shuo Zhang; Hua-Lei Qin; Tong Wang; Hai-Tao Li; Hai Li; Shi-Hai Xia; Xiao-Hui Xiang
Journal:  Springerplus       Date:  2015-12-14

8.  Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia.

Authors:  Isam Karam; Ning Ma; Xi-Wang Liu; Shi-Hong Li; Xiao-Jun Kong; Jian-Yong Li; Ya-Jun Yang
Journal:  BMC Vet Res       Date:  2015-08-20       Impact factor: 2.741

9.  Hawthorn ethanolic extracts with triterpenoids and flavonoids exert hepatoprotective effects and suppress the hypercholesterolemia-induced oxidative stress in rats.

Authors:  Ali Rezaei-Golmisheh; Hassan Malekinejad; Siamak Asri-Rezaei; Amir Abbas Farshid; Peyman Akbari
Journal:  Iran J Basic Med Sci       Date:  2015-07       Impact factor: 2.699

Review 10.  In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD).

Authors:  Giridhar Kanuri; Ina Bergheim
Journal:  Int J Mol Sci       Date:  2013-06-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.